Jorge Rosa Medeiros

Prof. Dr. Jorge Rosa Medeiros

Biotechnology Centre of Azores
+1

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2003 in Phytochemistry
Verified
Journal Article
Closed access
JMJorge Rosa Medeiros
Jorge Rosa Medeiros
LCLurdes B. Campos
Lurdes B. Campos
SMSusana C. Mendonça
Susana C. Mendonça
LDLaurence B. Davin
Laurence B. Davin
NLNorman G. Lewis
Norman G. Lewis

1 September 2000 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JMJorge Rosa Medeiros
Jorge Rosa Medeiros
MMManuelo Macedo
Manuelo Macedo
JCJoao P Contancia
Joao P Contancia
CNChi Nguyen
Chi Nguyen
GCGlenn Cunningham
Glenn Cunningham
DMD.HOward Miles
D.HOward Miles

10 February 2006 in Journal of Molecular Evolution
Verified
Journal Article
Closed access
PDF file
RMRafael Montiel
Rafael Montiel
MLMiguel A. Lucena
Miguel A. Lucena
JMJorge Rosa Medeiros
Jorge Rosa Medeiros
NSNelson Simões
Nelson Simões

23 November 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Ana LimaAna Lima
Ana Lima
Filipe ArrudaFilipe Arruda
Filipe Arruda
JMJorge Rosa Medeiros
Jorge Rosa Medeiros
JBJosé António Bettencourt Baptista
José António Bettencourt Baptista
JMJoão Madruga
João Madruga
Elisabete LimaElisabete Lima
Elisabete Lima
The scientific community is paying increasing attention to plant waste valorization, and also to “greener” practices in the agriculture, food and cosmetic sectors. In this context, unused forest biomass (e.g., leaves, seed cones, branches/twigs, bark and sapwood) of Cryptomeria japonica, a commercially important tree throughout Asia and the Azores Archipelago (Portugal), is currently waste/by-products of wood processing that can be converted into eco-friendly and high added-value products, such as essential oils (EOs), with social, environmental and economic impacts. Plant-derived EOs are complex mixtures of metabolites, mostly terpenes and terpenoids, with valuable bioactivities (e.g., antioxidant, anti-inflammatory, anticancer, neuroprotective, antidepressant, antimicrobial, antiviral and pesticide), which can find applications in several industries, such as pharmaceutical, medical, aromatherapy, food, cosmetic, perfumery, household and agrochemical (e.g., biopesticides), with manifold approaches. The EOs components are also of value for taxonomic investigations. It is known that the variation in EOs chemical composition and, consequently, in their biological activities and commercial use, is due to different exogenous and endogenous factors that can lead to ecotypes or chemotypes in the same plant species. The present paper aims to provide an overview of the chemical composition, biological properties and proposals of valorization of C. japonica EO from several countries, and also to indicate gaps in the current knowledge.

2 May 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Elisabete LimaElisabete Lima
Elisabete Lima
JMJorge Rosa Medeiros
Jorge Rosa Medeiros
Alzheimer’s disease (AD), a slowly progressive neurodegenerative disorder, is the main cause of dementia worldwide. However, currently, the approved drugs to combat AD are effective only in treating its symptoms. In fact, an efficacious treatment for this complex and multifactorial disorder remains to be discovered, demanding the urgent development of new therapeutic approaches for the disease, such as the use of bioactive secondary metabolites (SMs) from natural sources. Sessile organisms, like plants, are unable to escape from adverse environmental conditions and must therefore create their own defense. Their main defense strategy is chemical defense that includes the production of an enormously diverse array of bioactive SMs, such as terpenes and their derivatives. This largest and most diverse group of plant SMs also provide the treatment of several diseases due to their broad-spectrum bioactivities, for example, anticancer, antioxidant, and anti-inflammatory properties. Thus, the evaluation of the neuroprotective potential of terpenes is imperative. It is known that the major AD clinical indications (CIs) are extracellular senile plaques of amyloid-β (Aβ) protein, intracellular hyperphosphorylated tau (τ) neurofibrillary tangles (NFTs), uncommon neuroinflammatory response, oxidative stress, and synaptic and neuronal dysfunction. Therefore, terpenes that may decrease these CIs might be used for AD treatment. Surely, terpenes targeting more than one AD pathogenic mechanism, multi-target drug ligands (MTDLs), have the potential to become a leading AD treatment. Thus, this review analyzes, for each CI, the scaffolds of the selected terpenes leading to the highest activity.

11 April 2010 in Journal of Applied Entomology
Verified
Journal Article
Closed access
PDF file
José Silvino Santos Da RosaJosé Silvino Santos Da Rosa
José Silvino Santos Da Rosa
CMCarla Mascarenhas
Carla Mascarenhas
LOLuisa Oliveira
Luisa Oliveira
TTT. Teixeira
T. Teixeira
Maria do Carmo BarretoMaria do Carmo Barreto
Maria do Carmo Barreto
JMJorge Rosa Medeiros
Jorge Rosa Medeiros